Omalizumab inhibits allergen challenge-induced nasal responseHANF, G; NOGA, O; O'CONNOR, A et al.The European respiratory journal. 2004, Vol 23, Num 3, pp 414-418, issn 0903-1936, 5 p.Article

Intérêt d'un traitement par omalizumab dans le cadre d'une immunothérapie spécifique. Recueil d'expérience et analyse de la littérature = The interest of treatment with omalizumab in the framework of specific immunotherapyOSTER, J.-P; LAVAUD, F; BENTALEB, A et al.Revue française d'allergologie (Amsterdam. Print). 2014, Vol 54, Num 5, pp 347-355, issn 1877-0312, 9 p.Article

L'omalizumab est un traitement de recours efficace dans l'urticaire chronique résistante aux autres traitements = Omalizumab: an alternative therapy in chronic urticariaBEN SAÏD, Benoît; AUGEY, Frédéric; NOSBAUM, Audrey et al.Les Nouvelles dermatologiques. 2011, Vol 30, Num SEP, pp 372-373, issn 0752-5370, 2 p., CAH1Article

Efficacy of omalizumab in severe asthma with fungal sensitisation: a case reportDI STEFANO, F; CINTI, B; ANTONICELLI, L et al.European annals of allergy and clinical immunology. 2014, Vol 46, Num 1, pp 56-59, issn 1764-1489, 4 p.Article

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthmaBOUSQUET, J; SIERGIEJKO, Z; SWIEBOCKA, E et al.Allergy (Copenhagen). 2011, Vol 66, Num 5, pp 671-678, issn 0105-4538, 8 p.Article

Omalizumab-induced reductions in mast cell Fc∈RI expression and functionBECK, Lisa A; MARCOTTE, Gregory V; MACGLASHAN, Donald JR et al.Journal of allergy and clinical immunology. 2004, Vol 114, Num 3, pp 527-530, issn 0091-6749, 4 p.Article

CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment : Astham research still activeNOPP, A; JOHANSSON, S. G. O; ANKERST, J et al.Allergy (Copenhagen). 2007, Vol 62, Num 10, pp 1175-1181, issn 0105-4538, 7 p.Article

Characterization of an anaphylactoid reaction to omalizumabDREYFUS, David H; RANDOLPH, Christopher C.Annals of allergy, asthma, & immunology. 2006, Vol 96, Num 4, pp 624-627, issn 1081-1206, 4 p.Article

Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008LIN, Robert Y; RODRIGUEZ-BAEZ, Gerson; BHARGAVE, Geeta A et al.Annals of allergy, asthma, & immunology. 2009, Vol 103, Num 5, pp 442-445, issn 1081-1206, 4 p.Article

Effects of omalizumab in a patient with three types of chronic urticariaDOS SANTOS, R. Vieira; BIDESE, B. Locks; DE SOUZA, J. Rabello et al.British journal of dermatology (1951). 2014, Vol 170, Num 2, pp 469-471, issn 0007-0963, 3 p.Article

Response to: 'Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisal'ROSEN, K; MAURER, M; CASALE, T et al.British journal of dermatology (1951). 2014, Vol 171, Num 1, pp 15-16, issn 0007-0963, 2 p.Article

High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effectsBUSSE, William; SPECTOR, Sheldon; ROSEN, Karin et al.Journal of allergy and clinical immunology. 2013, Vol 132, Num 2, pp 485-486, issn 0091-6749, 2 p.Article

Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthmaKARPEL, Jill; MASSANARI, Marc; GEBA, Gregory P et al.Annals of allergy, asthma, & immunology. 2010, Vol 105, Num 6, pp 465-470, issn 1081-1206, 6 p.Article

THE SAFETY AND INTERPRETABILITY OF SKIN TESTS WITH OMALIZUMABLIEBERMAN, Phillip; RAHMAOUI, Abdelkader; WONG, Dennis A et al.Annals of allergy, asthma, & immunology. 2010, Vol 105, Num 6, pp 493-495, issn 1081-1206, 3 p.Article

Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticariaSABROE, R. A.British journal of dermatology (1951). 2014, Vol 171, Num 1, pp 13-15, issn 0007-0963, 3 p.Article

Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria: a critical appraisalDURACK, A; MATIN, R. N.British journal of dermatology (1951). 2014, Vol 171, Num 1, pp 10-13, issn 0007-0963, 4 p.Article

Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesisCORREN, Jonathan; DIAZ-SANCHEZ, David; SAXON, Andrew et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 3, pp 243-248, issn 1081-1206, 6 p.Article

Monitoring free serum IgE in severe asthma patients treated with omalizumabKORN, Stephanie; HAASLER, Ina; FLIEDNER, Florian et al.Respiratory medicine. 2012, Vol 106, Num 11, pp 1494-1500, issn 0954-6111, 7 p.Article

Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST studyBRUSSELLE, G; MICHILS, A; LECOMTE, P et al.Respiratory medicine. 2009, Vol 103, Num 11, pp 1633-1642, issn 0954-6111, 10 p.Article

Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma : An open-label studyNIVEN, R; CHUNG, K. F; PANAHLOO, Z et al.Respiratory medicine. 2008, Vol 102, Num 10, pp 1371-1378, issn 0954-6111, 8 p.Article

Omalizumab als therapeutische Alternative beim atopischen Ekzem : Bisherige Evidenz und potenzieller Nutzen : Antikörpertherapie = Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefitSCHMITT, J; SCHÄKEL, K.Hautarzt. 2007, Vol 58, Num 2, pp 128-132, issn 0017-8470, 5 p.Article

Cost-effectiveness of omalizumab in adults with severe asthma : Results from the Asthma Policy ModelWU, Ann C; PALTIEL, A. David; KUNTZ, Karen M et al.Journal of allergy and clinical immunology. 2007, Vol 120, Num 5, pp 1146-1152, issn 0091-6749, 7 p.Article

The size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair^®) treatmentJOHANSSON, S. G. O; NOPP, A; ÖMAN, H et al.Allergy (Copenhagen). 2009, Vol 64, Num 10, pp 1472-1477, issn 0105-4538, 6 p.Article

Asthma treatment : 'magic bullets which seek their own targets' : AsthmaTARANTINI, F; BAIARDINI, I; PASSALACQUA, G et al.Allergy (Copenhagen). 2007, Vol 62, Num 6, pp 605-610, issn 0105-4538, 6 p.Article

Basophil allergen threshold sensitivity : a useful approach to anti-ige treatment efficacy evaluation : Basophils and mast cellsNOPP, A; JOHANSSON, S. G. O; ANKERST, J et al.Allergy (Copenhagen). 2006, Vol 61, Num 3, pp 298-302, issn 0105-4538, 5 p.Article